Thoracoscopic lobectomy for non-small-cell lung cancer in patients with impaired pulmonary function: analysis from a national database
- 6 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 30 (6), 803-811
- https://doi.org/10.1093/icvts/ivaa044
Abstract
OBJECTIVES The objective of this retrospective multi-institutional study was to evaluate the postoperative outcomes of video-assisted thoracoscopic surgery (VATS)-lobectomy (VATS-L) for non-small-cell lung cancer (NSCLC) in patients with impaired lung function. The second end point was to illustrate the effective role of forced expiratory volume in 1 s (FEV1%) and the diffusing capacity of the lung for carbon monoxide (DLCO%) in predicting complications in this population. METHODS Data from patients who underwent VATS-L at participating centres were analysed and divided into 2 groups: group A comprised patients with FEV1% and/or DLCO% >60% and group B included patients with impaired lung function defined as FEV1% and/or DLCO% ≤60%. To define clinical predictors of death and complications, we performed univariate and multivariable regression analyses. RESULTS A total of 5562 patients underwent VATS-L, 809 (14.5%) of whom had impaired lung function. The postoperative mortality rate did not differ between the 2 groups (2.3% vs 3.2%; P = 0.77). The percentage of patients who had any complication (21.4% vs 34.2%; P ≤ 0.001), the complication rate (28% vs 49.8%; P ≤ 0.001) and the length of hospital stay (P ≤ 0.001) were higher for patients with limited pulmonary function. Impaired lung function was a strong predictor of overall and pulmonary complications at multivariable analysis. CONCLUSIONS VATS-L for NSCLC can be performed in patients with impaired lung function without increased risk of postoperative death and with an acceptable incidence of overall and respiratory complications. Our analysis suggested that FEV1% and DLCO% play a substantial role in estimating the risk of complications after VATS-L, but their role was less reliable for estimating the mortality.Keywords
This publication has 29 references indexed in Scilit:
- Perioperative outcomes of thoracoscopic anatomic resections in patients with limited pulmonary reserveThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Video-assisted thoracic surgery versus open lobectomy for lung cancer: A secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trialThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Pulmonary Function Tests Do Not Predict Pulmonary Complications After Thoracoscopic LobectomyThe Annals of Thoracic Surgery, 2010
- Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomyThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2009
- ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)European Respiratory Journal, 2009
- Video-Assisted Thoracic Surgery Lobectomy: Report of CALGB 39802—A Prospective, Multi-Institution Feasibility StudyJournal of Clinical Oncology, 2007
- Thoracoscopic Lobectomy Facilitates the Delivery of Chemotherapy after Resection for Lung CancerThe Annals of Thoracic Surgery, 2007
- Thoracoscopic Lobectomy Is a Safe and Versatile ProcedureAnnals of Surgery, 2006
- Lobectomy—video-assisted thoracic surgery versus muscle-sparing thoracotomy: A randomized trialThe Journal of Thoracic and Cardiovascular Surgery, 1995